Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06048224 |
|---|---|
| Brief Title: | Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis |
| First Submitted : | September 6, 2023 |
| First Submitted that Met QC Criteria : | September 14, 2023 |
| First Posted : | September 21, 2023 |
| Last Update Submitted that Met QC Criteria : | September 14, 2023 |
| Last Update Posted : | September 21, 2023 |